The stock of Immunotec Inc (CVE:IMM) is a huge mover today! About 70,000 shares traded hands or 1389.04% up from the average. Immunotec Inc (CVE:IMM) has risen 6.00% since October 8, 2016 and is uptrending. It has outperformed by 4.04% the S&P500.
The move comes after 9 months negative chart setup for the $25.46M company. It was reported on Nov, 7 by Barchart.com. We have $0.35 PT which if reached, will make CVE:IMM worth $2.55 million less.
More notable recent Immunotec Inc (CVE:IMM) news were published by: Marketwired.com which released: “Immunotec Inc.: Immunocal® Used in Novel Prehabilitation Study” on October 14, 2014, also Marketwired.com with their article: “Sigrid Beer Purchases 500000 Common Shares of Immunotec Inc. from Robert M …” published on March 28, 2014, Marketwired.com published: “Immunotec Announces Executive Promotions” on February 29, 2016. More interesting news about Immunotec Inc (CVE:IMM) were released by: Marketwired.com and their article: “Immunotec Reports 2014 Year-End Results” published on January 26, 2015 as well as Marketwatch.com‘s news article titled: “Immunotec Reports 2015 Year-End Results” with publication date: January 28, 2016.
Immunotec Inc. is a Canada-based company that develops, makes, markets and sells research-driven nutritional products through direct-to-consumer sales channels in Canada, the United States and Mexico. The company has a market cap of $25.46 million. The Firm also subcontracts certain distribution logistics and manufacturing capacity activities in the United States, Europe and Mexico to support its activities. It has a 8.36 P/E ratio. It makes and sells natural health products, dietary supplements and cosmetics, and sells them under a network marketing business model.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.